KRAS and pancreatic intraductal papillary-mucinous neoplasm: The mean age of IPMN patients with KRAS mutation ranged from 63.67 to 70.15 years, whereas the mean age of those with wild-type KRAS ranged from 64.3 to 68.58 years.